Prostacycline (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Prostacycline" in French language version.

refsWebsite

Global rank French rank

2atsjournals.org

low place

4,703^rd place

1,735^th place

168^th place

2,374^th place

298^th place

low place

1,894^th place

1sciencedirect.com

149^th place

80^th place

1ahajournals.org

3,608^th place

659^th place

ahajournals.org

circ.ahajournals.org

Jing ZC, Parikh K, Pulido T et al. Efficacy and safety of oral treprostinil monotherapy for the treatment of pulmonary arterial hypertension: a randomized controlled trial, Circulation, 2013;127:624–633

annals.org

Barst RJ, Rubin LJ, McGoon MD, Caldwell EJ, Long WA, Levy PS, Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin, Ann Intern Med, 1994;121:409–415

atsjournals.org

ajrccm.atsjournals.org

Tuder RM, Cool CD, Geraci MW et al. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension, Am J Respir Crit Care Med, 1999;159:1925–1932
Simonneau G, Barst RJ, Galie N et al. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial, Am J Respir Crit Care Med, 2002;165:800–804

nejm.org

Barst RJ, Rubin LJ, Long WA et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension, N Engl J Med, 1996;334:296–301

qmul.ac.uk

chem.qmul.ac.uk

Masse molaire calculée d’après « Atomic weights of the elements 2007 », sur www.chem.qmul.ac.uk.

sciencedirect.com

Shapiro SM, Oudiz RJ, Cao T, Romano MA et al. Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion, J Am Coll Cardiol, 1997;30:343–349